Adverts help to support the work of this non-profit organisation. To go ad-free join as a Member.

Geron

Started by caliban , Jun 14 2005 08:07 PM

Page 4 of 12
2
3
4
5
6

Please log in to reply

334 replies to this topic

#91 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 December 2010 - 11:55 AM

Geron Corp concludes USD93.5m public offering of common shares
Trading Markets - 42 minutes ago

Biopharmaceuticals company Geron Corp (Nasdaq: GERN | PowerRating) reported on Friday the completion of a public offering of 17,391,305 shares of its common stock. The underwriters also acquired 2 ...

View the full article

#92 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 December 2010 - 04:48 PM

Statman, Harris & Eyrich, LLC Announces Investigation Of Geron Corporation
TheStreet.com - 2 hours ago

By GlobeNewswire 12/13/10 - 11:45 AM EST The law firm of Statman, Harris & Eyrich, LLC, which has significant experience in class actions, announced today that it is investigating Geron ...

Statman, Harris & Eyrich, LLC Announces Investigation of Geron Corporation - Trading Markets

View the full article

#93 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 17 December 2010 - 01:25 PM

Stem Cell Gainers (CUR, ISCO, BTX, ASTM, GERN)
College Stock - 1 hour ago

Neuralstem Inc (AMEX:CUR) went up 6.45% and closed at $2.31 after the Company said that they have received FDA approval for its Investigational New Drug application to initiate a Phase Ia safety ...

View the full article

#94 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 22 December 2010 - 03:59 PM

Bernstein Liebhard LLP Announces Class Action Filed on Behalf of Investors in Geron Corporation
Business Wire - 1 hour ago

NEW YORK--(BUSINESS WIRE)--Bernstein Liebhard LLP today announced that an action has been filed in the United States District Court for the Northern District of California on behalf of purchasers ...

View the full article

#95 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 24 December 2010 - 12:35 AM

Hagens Berman Investigates Geron Corporation for Securities Violations
Business Wire - 5 minutes ago

SAN FRANCISCO--(BUSINESS WIRE)--Hagens Berman is investigating Geron Corp. (NASDAQ:GERN) on behalf of investors after a lawsuit claims the biopharmaceuticals company violated the Securities ...

View the full article

#96 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 25 December 2010 - 02:23 AM

Geron Corporation (GERN) Corporate Event Announcement Notice
Trading Markets - 2 hours ago

For full details on Geron Corporation (GERN) GERN. Geron Corporation (GERN) has Short Term PowerRatings at TradingMarkets. Details on Geron Corporation (GERN) Short Term PowerRatings is available ...

View the full article

#97 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 27 December 2010 - 07:12 AM

Geron Corporation hit by investor lawsuit
PR-USA.net - 9 hours ago

If you purchased Geron Corporation (NASDAQ:GERN) common stock during the period July 31, 2010 and December 6, 2010, you have certain options and there are strict and short deadlines running ...

View the full article

#98 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 28 December 2010 - 03:35 AM

Shareholder Claims Against Geron Corporation Investigated by Goldfarb Branham LLP
Business Wire - 2 hours ago

DALLAS--(BUSINESS WIRE)--Goldfarb Branham LLP is investigating whether certain officers and directors of Geron Corporation, Inc. (NASDAQ: GERN) violated securities laws due to statements about the ...

Goldfarb Branham Investigates Shareholder Claims Against Geron - Quick Facts - RTT News

View the full article

#99 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 28 December 2010 - 03:33 AM

Goldfarb Branham LLP Investigates Shareholder Claims Against Geron Corporation
Reuters Key Development - 2 hours ago

View the full article

#100 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 29 December 2010 - 07:02 AM

Geron Corporation hit by investor lawsuit over alleged securities laws violations
PR-CANADA.net - 6 hours ago

An investor in Geron Corporation (NASDAQ:GERN) shares filed a lawsuit in the United States District Court for the Northern District of California against Geron Corp over alleged violations of ...

NDAQ, TQNT, LULU, ERTS, GERN - Notable Stocks with Volume at NASDAQ - TapeBeat

View the full article

#101 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 04 January 2011 - 01:26 AM

Biotechnology Stock in Focus; Geron Corporation (GERN)
Tech24 - 15 hours ago

Geron Corporation (NASDAQ: GERN) is a Menlo Park, California-based biopharmaceutical company. The company focuses in the development of biopharmaceuticals for the treatment of cancer and chronic ...

View the full article

#102 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 07 January 2011 - 12:31 PM

Geron to Present at J.P. Morgan Annual Healthcare Conference
Business Wire - 2 hours ago

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced that Thomas B. Okarma, Ph.D., MD, president and chief executive officer, will present an update of the company ...

View the full article

#103 caliban

Topic Starter
Admin, Advisor, Director
9,163 posts
609 ₮

Location:UK
✔

Posted 07 January 2011 - 05:46 PM

RE lawsuit: any views out there?

Just a bubbled that needed bursting or something fishy?

#104 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 08 January 2011 - 01:17 AM

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Geron Corporation, Announces Class Action Lawsuit and Seeks to Recover Losses
Business Wire - 3 hours ago

LOS ANGELES--(BUSINESS WIRE)--Notice is hereby given that Glancy Binkow & Goldberg LLP has filed a class action lawsuit in the United States District Court for the Northern District of California ...

Glancy Binkow & Goldberg LLP, Representing Investors Who Purchased Geron Corporation, Announces Class Action Lawsuit and See - Trading Markets
Glancy Binkow & Goldberg Files Class Action Suit Against Geron - Quick Facts - RTT News
Stock Markets Review

View the full article

#105 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 10 January 2011 - 12:40 PM

Geron (GERN) Publishes GRN163L Preclinical Data
StreetInsider.com - 4 minutes ago

The data published was GRN163L in targeting cancer stem cells in pediatric tumors of neural origin. "The data in the current study showed that telomerase activity was confined to the cancer stem ...

View the full article

#106 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 10 January 2011 - 12:31 PM

Geron Announces Publication Demonstrating Activity of Imetelstat Against Cancer Stem Cells From Pediatric Neural Tumors
Business Wire - 13 minutes ago

MENLO PARK, Calif.--(BUSINESS WIRE)--Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat ...

View the full article

#107 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 10 January 2011 - 05:11 PM

Stocks with Volume Spikes on Monday - ERIC, GERN, JDSU, ERTS, ENER
Savvy Stock Picks - 2 hours ago

Telefonaktiebolaget LM Ericsson (ADR) (NASDAQ:ERIC) increased 0.45%, currently trading at $11.11 and its overall traded volume was 1.07M shares while reporting, against its average volume of 4.05M ...

View the full article

#108 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 11 January 2011 - 08:35 AM

COST, AMMD, MNKD, GERN, IDTI - Notable Stocks with Volume at NASDAQ
TapeBeat - 1 hour ago

Costco Wholesale Corporation (NASDAQ:COST) fell -0.24%, to close at $70.48 and its overall traded volume was 2.07M shares on Monday, with the total traded volume of 3.11M shares. COST opened at ...

View the full article

#109 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 11 January 2011 - 11:07 AM

Study supports use of telomerase inhibitors for treatment of childhood cancers
News-Medical.net - 2 hours ago

Geron Corporation (Nasdaq:GERN) today announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical ...

View the full article

#110 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 12 January 2011 - 12:55 PM

Geron announces pre clinical data from telomerase inhibitor drug imetelstat against cancer stem cells from paediatric neural tumours
pharmabiz.com - 50 minutes ago

Geron Corporation announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat (GRN163L), currently in phase II clinical trials, selectively ...

View the full article

#111 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 12 January 2011 - 10:35 AM

SBAC, ANAD, JRCC, NTES, GERN â€“ Stocks to watch on Wednesday
Savvy Stock Picks - 3 hours ago

SBA Communications Corporation (NASDAQ:SBAC) percentage change grew 0.18%, to close at $39.63 and its overall traded volume was 1.14M shares during the last session, with the total traded volume ...

View the full article

#112 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 January 2011 - 05:36 AM

Geron Publishes Research Demonstrating Activity of Imetelstat Against Cancer Stem Cells from Pediatric Neural Tumors
Trading Markets - 1 hour ago

Geron Corporation, a developer of biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, announced the publication of preclinical data demonstrating that the company's ...

View the full article

#113 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 January 2011 - 05:14 AM

Geron Corporation Hit By Investor Lawsuit Over Alleged Securities Laws Violations
The Open Press - 2 hours ago

(OPENPRESS) January 13, 2011 -- An investor in Geron Corporation (NASDAQ:GERN) shares filed a lawsuit in the United States District Court for the Northern District of California against Geron Corp ...

View the full article

#114 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 January 2011 - 01:56 PM

Stocks In News (SSNC, CLSN, GERN, BTI)
Your Stock Alert - 20 minutes ago

SS&C Technologies Holdings, Inc. (NASDAQ:SSNC) shares slumped over 5.50% in the pre-market session after the company late Wednesday said that it intends to offer 2 million shares of common stock ...

View the full article

#115 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 January 2011 - 05:19 PM

TOP 5 COMPANIES IN THE HEALTHCARE SECTOR WITH THE LOWEST RELATIVE PERFORMANCE (MRK, JAZZ, GERN, PRXL, SVNT)
Zacks.com - 28 minutes ago

Jan 13, 2011 (SmarTrend® Market Surveillance via COMTEX) -- Below are the top five companies in the Healthcare sector as measured by relative performance. Lowest relative performance is a ...

View the full article

#116 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 13 January 2011 - 06:31 PM

New US Patent Covers Breakthrough in Anti-Aging Science
PharmaLive - 2 hours ago

NEW YORK, Jan. 13, 2011 /PRNewswire/ -- Telomerase Activation Sciences, Inc. (TA Sciences) today announced the issuance of US Patent No. 7,846,904 to the Geron Corporation. The patent covers the ...

Anti Aging: New Breakthrough Just Patented in U.S. - San Francisco Bay Area Today

View the full article

#117 kmoody

Guest, F@H
202 posts
240 ₮

Location:Syracuse, NY

Posted 14 January 2011 - 05:01 AM

Not sure about the actual telomerase promoting activity of the product, but if you look at TA Science's website all of the "efficacy" data they boast is self report data from patients. If you look at the graphs only two data points (out of 13) are statistically significant, and at least one can easily be explained by placebo effect. If this was actually useful as a therapeutic it would be in clinical trials. Instead it is being sold as a supplement after being on the market for 6 years. Not impressive.

#118 niner

Guest
16,276 posts
2,000 ₮

Location:Philadelphia

Posted 14 January 2011 - 07:02 AM

Not sure about the actual telomerase promoting activity of the product, but if you look at TA Science's website all of the "efficacy" data they boast is self report data from patients. If you look at the graphs only two data points (out of 13) are statistically significant, and at least one can easily be explained by placebo effect. If this was actually useful as a therapeutic it would be in clinical trials. Instead it is being sold as a supplement after being on the market for 6 years. Not impressive.

I thought the paper in Rej Res was a little better than that, but I don't know what to make of this patent puffery. It's a PR Newswire piece citing a no-name Bay Area paper. That seems self-promotional. That doesn't mean TA65 is worthless, but it doesn't mean it works either. I'm at the level of "toying with the idea" of trying cycloastragenol. One of these days I'll get a CMV antibody titer; if it's positive (which is likely) that would be another item that would encourage me to give it a go.

As for it being sold as a supplement, it's a natural product that falls into the supplement classification, isn't it? I think at best they could patent a formulation. I'm not sure if the concept of a 'use patent' would apply here. They could modify the molecule and go for a New Chemical Entity, but that would only fly if it was significantly better than the original, would be very expensive, and would require FDA approval. I suspect they explored that route and weren't successful with it, though I don't know that for sure.

#119 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 14 January 2011 - 06:56 AM

TA Sciences receives US patent for TA-65 to tackle aging process
News-Medical.net - 50 minutes ago

Telomerase Activation Sciences, Inc. (TA Sciences) today announced the issuance of US Patent No. 7,846,904 to the Geron Corporation. The patent covers the use of certain compounds to upregulate ...

View the full article

#120 ImmInst

Admin, Director robot
2,357 posts
73 ₮

Posted 14 January 2011 - 07:11 AM

Geron Publishes Preclinical Data Demonstrating Activity of Imetelstat against Cancer Stem Cells from Pediatric Neural Tumors
Trading Markets - 4 hours ago

Geron Corp. has announced the publication of preclinical data demonstrating that the company's telomerase inhibitor drug, imetelstat (GRN163L), currently in Phase 2 clinical trials, selectively ...

View the full article